Portage regains full compliance with Nasdaq continued listing requirements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2025
0mins
Should l Buy ?
Compliance Notification: Portage Biotech received formal notice from The Nasdaq Stock Market confirming compliance with all requirements for continued listing on the Nasdaq Capital Market.
Date of Notification: This notification was received on June 24, 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
